Cytasted 1gm (Cytarabine Vials) 1gm/10ml

Cytasted 1gm is a sterile injectable vial containing cytarabine, a chemotherapy agent used in cancer treatment. Store below 25°C and protect from light. Always follow healthcare provider instructions for use. Suitable for oncology protocols requiring cytarabine 1gm per 10ml.

Strength

1gm/10ml

Pack Size

Storage

Below 25°C

Manufacturer / TM Owner

Halsted Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cytasted 1gm (cytarabine) is used as part of chemotherapy regimens for certain cancers, including leukemia and lymphoma. It works by interfering with cancer cell growth. Healthcare professionals determine specific treatment protocols based on individual patient needs. Commonly prescribed for acute myeloid leukemia and other hematologic malignancies.

Side Effects

Cytarabine may cause temporary effects such as nausea, fatigue, or lowered blood cell counts during treatment. These effects vary by patient and treatment stage. Some individuals experience mild discomfort at the injection site. Always report persistent or severe reactions to a healthcare provider.

Precautions & Warnings

Keep Cytasted 1gm vials refrigerated below 25°C and protected from light until use. Handle with care to avoid contamination or spills. Use only as directed by a qualified medical professional. Discard any unused portion according to local regulations for cytotoxic drugs.

Avoid Interactions

Cytarabine may interact with other medications affecting bone marrow function or liver enzymes. Avoid alcohol and herbal supplements unless approved by a doctor. Some vaccines may have reduced effectiveness during treatment. Always inform your healthcare provider about all medications being taken.

References

Frequently Asked Questions

Cytasted 1gm contains cytarabine and is prescribed for certain cancers like leukemia and lymphoma as part of chemotherapy.

Store below 25°C and protect from light; do not freeze. Follow healthcare provider instructions for preparation and administration.

No, this medication requires administration by a healthcare professional in a clinical setting due to its potency.

Common effects may include nausea, fatigue, or lowered blood cell counts; report severe reactions to your doctor.

Consult a healthcare provider; cytarabine may harm unborn babies and should only be used if clearly needed.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.